JP2013535483A - Ｐ２４タンパク質の産生を阻害するか又は排出を促進する医薬組成物及び方法 - Google Patents

Ｐ２４タンパク質の産生を阻害するか又は排出を促進する医薬組成物及び方法 Download PDF

Info

Publication number
JP2013535483A
JP2013535483A JP2013522317A JP2013522317A JP2013535483A JP 2013535483 A JP2013535483 A JP 2013535483A JP 2013522317 A JP2013522317 A JP 2013522317A JP 2013522317 A JP2013522317 A JP 2013522317A JP 2013535483 A JP2013535483 A JP 2013535483A
Authority
JP
Japan
Prior art keywords
activation
receptor
antibody
seq
dilution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013522317A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013535483A5 (enExample
Inventor
イリイチ・エプシテイン オレグ
アレクサンドロヴィッチ・タラソワ セルゲイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2013535483A publication Critical patent/JP2013535483A/ja
Publication of JP2013535483A5 publication Critical patent/JP2013535483A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2013522317A 2010-08-06 2011-07-15 Ｐ２４タンパク質の産生を阻害するか又は排出を促進する医薬組成物及び方法 Pending JP2013535483A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2010133046/15A RU2517084C2 (ru) 2010-08-06 2010-08-06 Способ и средство для ингибирования продукции или усиления элиминации белка р24
RU2010133046 2010-08-06
PCT/IB2011/002355 WO2012017322A2 (en) 2010-08-06 2011-07-15 Pharmaceutical composition and method of inhibiting of production or amplifying elimination of p24 protein

Publications (2)

Publication Number Publication Date
JP2013535483A true JP2013535483A (ja) 2013-09-12
JP2013535483A5 JP2013535483A5 (enExample) 2014-04-24

Family

ID=44899160

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013522317A Pending JP2013535483A (ja) 2010-08-06 2011-07-15 Ｐ２４タンパク質の産生を阻害するか又は排出を促進する医薬組成物及び方法

Country Status (16)

Country Link
US (2) US20120263726A1 (enExample)
JP (1) JP2013535483A (enExample)
CN (1) CN103179987A (enExample)
AU (1) AU2011287286A1 (enExample)
CA (1) CA2807523A1 (enExample)
DE (1) DE112011102639T5 (enExample)
EA (1) EA029791B1 (enExample)
ES (1) ES2415029R1 (enExample)
GB (1) GB2496356A (enExample)
IT (1) ITTO20110636A1 (enExample)
MX (1) MX2013001450A (enExample)
PH (1) PH12013500233A1 (enExample)
RU (1) RU2517084C2 (enExample)
SG (1) SG187735A1 (enExample)
UA (1) UA112752C2 (enExample)
WO (1) WO2012017322A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
MX2013000543A (es) 2010-07-15 2013-10-28 Oleg Iliich Epshtein Un metodo para aumentar el efecto de una forma activa potenciada de un anticuerpo.
FR2962652A1 (fr) 2010-07-15 2012-01-20 Oleg Iliich Epshtein Composition pharmaceutique d'association et son utilisation dans des procedes pour traiter les maladies ou affections associees a des maladies neurodegeneratives
PH12013500144A1 (en) 2010-07-21 2018-03-21 Oleg Iliich Epshtein A method of treating attention deficit hyperactivity disorder
RU2013111961A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2013111962A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2603623C2 (ru) * 2014-06-06 2016-11-27 Олег Ильич Эпштейн Ветеринарная композиция и способ улучшения жизнеспособности животных, стимуляции прироста живой массы млекопитающих и птиц, повышения эффективности иммунизации, профилактики и/или лечения инфекционных заболеваний (варианты)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4236069A1 (de) * 1992-10-26 1994-04-28 Werner Dr Bergmann Arzneimittel, insbesondere für orale Einnahme
JPH08509500A (ja) * 1993-04-23 1996-10-08 トリプレックス・ファーマスーティカル・コーポレィション 抗ウイルス性グアノシンリッチオリゴヌクレオチド
WO2004002511A1 (ja) * 2002-06-28 2004-01-08 Fuso Pharmaceutical Industries, Ltd. 抗ｈｉｖ剤
JP2009080118A (ja) * 1996-10-10 2009-04-16 Probe Internatl ウイルス感染を処置するための組成物および方法
US20100166762A1 (en) * 2000-06-20 2010-07-01 Oleg Iliich Epshtein Method of treating a pathological syndrome

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311897A (en) 1979-08-28 1982-01-19 Union Carbide Corporation Plasma arc torch and nozzle assembly
AU6941000A (en) * 1999-08-27 2001-03-26 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Polypeptides that bind hiv gp120 and related nucleic acids, antibodies, compositions, and methods of use
WO2001043779A2 (en) * 1999-12-16 2001-06-21 Tanox, Inc. Anti-hiv-1 conjugates for treatment of hiv disease
RU2001134982A (ru) * 2001-12-26 2004-02-20 Олег Ильич Эпштейн Способ коррекции иммунного ответа и лекарственное средство
UA76641C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
AP2005003294A0 (en) * 2002-09-27 2005-06-30 Tanox Inc Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
GB2414670B (en) 2003-03-14 2008-03-19 Nutrition Res Inc Homeopathic formulations useful for treating pain and/or inflammation
RU2393873C2 (ru) * 2005-05-02 2010-07-10 Майметикс Корпорейшн Антитело или его фрагмент, имеющие нейтрализующую активность в отношении вич, но не в отношении il2
RU2315058C1 (ru) * 2006-09-27 2008-01-20 Институт органической химии Уфимского научного центра РАН Гликопептид глицирризиновой кислоты с глицил-l-фенилаланином, проявляющий анти-вич-1 активность
US20120263725A1 (en) * 2010-08-06 2012-10-18 Epshtein Oleg Iiiich Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4236069A1 (de) * 1992-10-26 1994-04-28 Werner Dr Bergmann Arzneimittel, insbesondere für orale Einnahme
JPH08509500A (ja) * 1993-04-23 1996-10-08 トリプレックス・ファーマスーティカル・コーポレィション 抗ウイルス性グアノシンリッチオリゴヌクレオチド
JP2009080118A (ja) * 1996-10-10 2009-04-16 Probe Internatl ウイルス感染を処置するための組成物および方法
US20100166762A1 (en) * 2000-06-20 2010-07-01 Oleg Iliich Epshtein Method of treating a pathological syndrome
WO2004002511A1 (ja) * 2002-06-28 2004-01-08 Fuso Pharmaceutical Industries, Ltd. 抗ｈｉｖ剤

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BLOOD, 1993, VOL.81, P.1808-1818, JPN6015013121, ISSN: 0003043304 *
BLOOD, 1993, VOL.81, P.2664-2670, JPN6015013120, ISSN: 0003043303 *
東方医学, 2007, VOL.23, NO.2, P.21-33, JPN6015013118, ISSN: 0003043302 *

Also Published As

Publication number Publication date
ES2415029R1 (es) 2013-09-17
US20130315964A1 (en) 2013-11-28
MX2013001450A (es) 2013-10-25
US20120263726A1 (en) 2012-10-18
WO2012017322A3 (en) 2012-04-19
WO2012017322A2 (en) 2012-02-09
EA201300138A1 (ru) 2014-03-31
UA112752C2 (uk) 2016-10-25
RU2010133046A (ru) 2012-02-20
SG187735A1 (en) 2013-03-28
GB2496356A (en) 2013-05-08
AU2011287286A1 (en) 2013-03-14
ES2415029A2 (es) 2013-07-23
CN103179987A (zh) 2013-06-26
RU2517084C2 (ru) 2014-05-27
CA2807523A1 (en) 2012-02-09
GB201303865D0 (en) 2013-04-17
EA029791B1 (ru) 2018-05-31
ES2415029A8 (es) 2013-09-16
PH12013500233A1 (en) 2017-08-23
DE112011102639T5 (de) 2013-10-02
ITTO20110636A1 (it) 2012-02-07

Similar Documents

Publication Publication Date Title
AU2011287292B2 (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
US20120294899A1 (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
JP2013535483A (ja) Ｐ２４タンパク質の産生を阻害するか又は排出を促進する医薬組成物及び方法
RU2535033C2 (ru) Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
US20120263725A1 (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
RU2517085C2 (ru) Комплексное лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2523451C2 (ru) Способ лечения хронической сердечной недостаточности и фармацевтическая композиция для лечения хронической сердечной недостаточности
WO2012017327A2 (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by hiv or associated with hiv
RU2525155C2 (ru) Способ лечения хронической сердечной недостаточности и фармацевтическая композиция для комплексной терапии хронической сердечной недостаточности
RU2441023C1 (ru) Лекарственное средство для лечения рассеянного склероза и способ лечения рассеянного склероза
CA2807529A1 (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140306

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140319

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150407

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20151006